Literature DB >> 19808069

Breakout session summary from AAPS/CRS joint workshop on critical variables in the in vitro and in vivo performance of parenteral sustained release products.

Marilyn N Martinez1, Michael J Rathbone, Diane Burgess, Mai Huynh.   

Abstract

Parenteral drug delivery systems can be designed to provide the flexible delivery characteristics needed in an evolving therapeutic landscape. The goal of some parenteral formulations is to maintain effective drug concentrations over a period of months or years, thereby enhancing patient compliance. When functioning as intended, these formulations can be used to minimize undesirable effects that may occur in response to the fluctuating drug concentrations effected by immediate release products. In other cases, targeted parenteral delivery systems allow for the deposition of drug directly to its site of action, thereby minimizing systemic toxicity. While these novel formulations can be beneficial to both human and veterinary patients, disastrous effects can occur if there is an unanticipated change in product quality or performance. With these thoughts in mind, the Controlled Release Society (CRS) hosted a 2007 workshop entitled "In Vitro and In Vivo Considerations Associated with Parenteral Sustained Release Products". The objective of that workshop was to explore the physicochemical properties of parenteral products and the factors that could alter their in vitro and in vivo performance characteristics. The outcomes of that workshop were summarized in a Journal of Controlled Release article. In response to questions raised during that workshop, the CRS and the American Association of Pharmaceutical Scientist (AAPS) co-hosted the follow-up 2008 workshop entitled "Critical Variables in the In Vitro and In Vivo Performance of Parenteral Sustained Release Products". This 2008 workshop provided a platform for exploring the application of design space concepts to these complex pharmaceuticals, and to consider the corresponding in vitro test methods that can be used to set batch release specifications. To foster discussion, the workshop provided two afternoon breakout sessions where critical questions were explored. This manuscript captures the results of those discussions. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2009        PMID: 19808069     DOI: 10.1016/j.jconrel.2009.09.028

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  9 in total

1.  In vitro-in vivo correlation of parenteral risperidone polymeric microspheres.

Authors:  Jie Shen; Stephanie Choi; Wen Qu; Yan Wang; Diane J Burgess
Journal:  J Control Release       Date:  2015-09-28       Impact factor: 9.776

Review 2.  Accelerated in-vitro release testing methods for extended-release parenteral dosage forms.

Authors:  Jie Shen; Diane J Burgess
Journal:  J Pharm Pharmacol       Date:  2012-03-08       Impact factor: 3.765

3.  IVIVC of Octreotide in PLGA-Glucose Microsphere Formulation, Sandostatin® LAR.

Authors:  Jin-Sook Song; So-Yeon Kim; Jae-Hyun Nam; Jaehwi Lee; Sang-Yong Song; Hasoo Seong
Journal:  AAPS PharmSciTech       Date:  2022-09-19       Impact factor: 4.026

4.  In Vitro Dissolution Testing Strategies for Nanoparticulate Drug Delivery Systems: Recent Developments and Challenges.

Authors:  Jie Shen; Diane J Burgess
Journal:  Drug Deliv Transl Res       Date:  2013-10-01       Impact factor: 4.617

5.  A reproducible accelerated in vitro release testing method for PLGA microspheres.

Authors:  Jie Shen; Kyulim Lee; Stephanie Choi; Wen Qu; Yan Wang; Diane J Burgess
Journal:  Int J Pharm       Date:  2015-12-15       Impact factor: 5.875

6.  A method of elevated temperatures coupled with magnetic stirring to predict real time release from long acting progesterone PLGA microspheres.

Authors:  Mingzhu Ye; Hongliang Duan; Lixia Yao; Yicheng Fang; Xiaoyu Zhang; Ling Dong; Feifei Yang; Xinggang Yang; Weisan Pan
Journal:  Asian J Pharm Sci       Date:  2018-08-14       Impact factor: 6.598

7.  Muscle Tissue as a Surrogate for In Vitro Drug Release Testing of Parenteral Depot Microspheres.

Authors:  Jan Kozak; Miloslava Rabiskova; Alf Lamprecht
Journal:  AAPS PharmSciTech       Date:  2021-03-29       Impact factor: 3.246

Review 8.  Seaweed Components as Potential Modulators of the Gut Microbiota.

Authors:  Emer Shannon; Michael Conlon; Maria Hayes
Journal:  Mar Drugs       Date:  2021-06-23       Impact factor: 5.118

Review 9.  Challenges and Complications of Poly(lactic-co-glycolic acid)-Based Long-Acting Drug Product Development.

Authors:  Yi Wen Lim; Wen Siang Tan; Kok Lian Ho; Abdul Razak Mariatulqabtiah; Noor Hayaty Abu Kasim; Noorsaadah Abd Rahman; Tin Wui Wong; Chin Fei Chee
Journal:  Pharmaceutics       Date:  2022-03-11       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.